04 November 2026, Mumbai, IN: Hikal Limited has signed a multi-year contract development and manufacturing agreement with a Europe-based global agrochemical company, the Mumbai-based company announced on November 2. The specialized agrochemical product at the center of the deal will be manufactured by Hikal’s Crop Protection division after nearly three years of joint process development and scale-up work with the undisclosed European partner, with commercial production expected to begin toward the end of the 2027 financial year.
Hikal did not disclose the identity of the contracting company, the specific molecule involved or the contract’s financial value, citing the confidentiality terms typical of contract manufacturing agreements in the agrochemical industry. The company described the arrangement only as a long-term commercial partnership, with sales volumes expected to rise over time as the customer secures the regulatory approvals it needs in its target markets. Sameer Hiremath, chairman and managing director of Hikal, said the agreement turns years of collaborative development work into a structured, long-term commercial relationship with the European company.
Three years of joint development work
The nearly three-year development timeline described by Hikal reflects the typical path for a contract manufacturing relationship in crop protection, where a customer’s proprietary active ingredient or intermediate must be scaled from laboratory or pilot quantities to commercial volumes before a manufacturing partner can begin regular production. Hikal’s Crop Protection division handles custom synthesis and manufacturing of active ingredients and intermediates for global agrochemical companies, alongside the company’s separate pharmaceutical contract manufacturing business.
The announcement comes within weeks of Hikal’s shareholders approving a fresh five-year term for Hiremath as chairman and managing director, running from October 1, 2026 through September 30, 2031, a decision taken at the company’s annual general meeting and reported publicly on September 24. Hikal has pursued long-term contract manufacturing relationships across both its pharmaceutical and crop protection businesses for more than a decade, including a previously disclosed ten-year multi-product agreement with a global pharmaceutical company. The new agrochemical contract extends that strategy into the crop protection side of the business at a time when global agrochemical makers have been looking to diversify their supply chains away from single-country sourcing.
Part of a wider trend toward India-based manufacturing
India’s contract development and manufacturing sector for agrochemicals has drawn growing interest from multinational crop protection companies seeking manufacturing partners outside China, citing the need for more diversified and resilient supply chains. Hikal has positioned its crop protection unit to compete for this kind of long-term outsourcing work, which typically requires years of joint technical development before a customer commits to a multi-year supply commitment of the kind announced this week.
Hikal operates manufacturing facilities across multiple sites in India and has built its crop protection business around both proprietary technical-grade products and custom manufacturing for third parties. The company’s decision to keep the counterparty and the product confidential is consistent with standard practice in the sector, where agrochemical innovators routinely require manufacturing partners to sign non-disclosure agreements covering both the identity of the molecule and the commercial terms of the relationship, given the competitive sensitivity of new active ingredients still working through global regulatory approval processes.
For Hikal, the contract adds a new multi-year revenue stream to its crop protection division without requiring additional capital investment in new manufacturing capacity, based on the company’s own description of the deal. The gradual ramp in volumes tied to the customer’s regulatory approval timeline means the financial impact on Hikal’s crop protection revenue is likely to build gradually over the next several years rather than arrive as an immediate step change, a pattern consistent with how similar custom manufacturing agreements in the sector have typically unfolded for Indian agrochemical producers.
Global Agriculture is an independent international media platform covering agri-business, policy, technology, and sustainability. For editorial collaborations, thought leadership, and strategic communications, write to pr@global-agriculture.com
